Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicity

Cancer
Jonathan W FriedbergGeorge P Canellos

Abstract

Gemcitabine is an effective treatment for recurrent Hodgkin disease (HD), with relatively minimal associated toxicity. The authors conducted a trial substituting this drug for dacarbazine in the standard regimen to form ABVG (doxorubicin, bleomycin, vinblastine, gemcitabine) for patients with newly diagnosed, high-risk HD. Twelve patients (median age, 34 years) with advanced-stage de novo HD were enrolled. Standard doses of doxorubicin, bleomycin, and vinblastine were given for six cycles. Cohorts of three patients were enrolled and the dose of gemcitabine was escalated to identify the maximally tolerated dose in this combination. The maximally tolerated dose of gemcitabine was determined to be 800 mg/m(2) in this combination. Five patients developed clinically significant pulmonary toxicity. Three required hospitalization during the final two cycles of treatment. Pneumonitis could not be predicted with serial diffusion capacity for carbon monoxide (DECO) evaluations, and reversed after discontinuation of bleomycin in three patients and steroid therapy in two patients. All 12 patients are alive to date, and 4 patients have experienced disease progression. The bleomycin/gemcitabine combination should not be pursued for de novo H...Continue Reading

References

Nov 19, 1992·The New England Journal of Medicine·George P CanellosBruce A Peterson
Nov 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T A ListerM Tubiana
Sep 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F G Haluska
Oct 29, 1999·Journal of Cancer Research and Clinical Oncology·A Sauer-HeilbornK Höffken
May 24, 2000·The Netherlands Journal of Medicine·R K LinskensG Giaccone
Jul 13, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A SantoroVolker Diehl
Jul 25, 2000·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·L J Johnston, S J Horning
Mar 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A SuredaGrupo Español de Linformas/Transplante Autólogo de Médula Osea Spanish Cooperative Group
Feb 2, 2002·American Journal of Clinical Oncology·Niraj GuptaBhoomi Mehrotra
May 3, 2002·The New England Journal of Medicine·George P Canellos, Donna Niedzwiecki
May 23, 2002·International Journal of Radiation Oncology, Biology, Physics·Melenda D JeterRavi Salgia
Feb 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Volker Diehl
Feb 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David B DugganBruce A Peterson

Citations

Sep 7, 2004·Cancer Chemotherapy and Pharmacology·Olatoyosi M OdenikeRichard A Larson
Jul 1, 2007·Current Hematologic Malignancy Reports·Bruce D Cheson
May 4, 2010·Current Hematologic Malignancy Reports·David W Dougherty, Jonathan W Friedberg
May 28, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J H MendlerJonathan W Friedberg
Apr 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K A BlumCancer and Leukemia Group B
Aug 9, 2006·Current Opinion in Oncology·David J Straus
Jun 23, 2011·Clinical Medicine Insights. Oncology·Amanda M SherrodShannon Puhalla
May 3, 2008·Leukemia & Lymphoma·Yasuhiro Oki, Anas Younes
Aug 15, 2006·International Journal of Radiation Oncology, Biology, Physics·Eng-Siew KohMary K Gospodarowicz
Feb 14, 2006·Seminars in Oncology·Mark MeadorsMichael C Perry
Apr 12, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Paolo AnderliniRichard E Champlin
Oct 16, 2016·International Journal of Radiation Oncology, Biology, Physics·Zeinab Abou YehiaBouthaina S Dabaja
Feb 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joachim Yahalom
Sep 19, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Graça M DoresLindsay M Morton
May 21, 2011·Blood·Jonathan W Friedberg
Oct 18, 2018·Journal of Clinical Medicine·Sarah SkeochNazia Chaudhuri

Related Concepts

Abvg Protocol
Antineoplastic Chemotherapy Protocols
Deoxycytidine
Ribodoxo
Hodgkin Lymphoma, Lymphocyte Depletion
Intravenous Infusion Procedures
Experimental Lung Inflammation
Cellblastin

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Synthetic Genetic Array Analysis

Synthetic genetic arrays allow the systematic examination of genetic interactions. Here is the latest research focusing on synthetic genetic arrays and their analyses.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Computational Methods for Protein Structures

Computational methods employing machine learning algorithms are powerful tools that can be used to predict the effect of mutations on protein structure. This is important in neurodegenerative disorders, where some mutations can cause the formation of toxic protein aggregations. This feed follows the latests insights into the relationships between mutation and protein structure leading to better understanding of disease.

Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Epigenetic Memory

Epigenetic memory refers to the heritable genetic changes that are not explained by the DNA sequence. Find the latest research on epigenetic memory here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Femoral Neoplasms

Femoral Neoplasms are bone tumors that arise in the femur. Discover the latest research on femoral neoplasms here.